# OnCo record trial-phases (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/trial-phases/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "trial-phases" ;
  schema:name "Phase 1, 2 and 3 trials"@en ;
  schema:alternateName "phase 1"@en, "phase 2"@en, "phase 3"@en, "phase I"@en, "phase II"@en, "phase III"@en, "phase 1/2"@en, "phase I/II"@en, "phase 2/3"@en, "phase II/III"@en, "phase 4"@en, "phase IV"@en, "first-in-human"@en, "first in human"@en, "dose-escalation"@en, "dose escalation"@en, "dose-finding"@en, "pivotal trial"@en, "pivotal trials"@en, "pivotal"@en, "registrational"@en, "confirmatory trial"@en, "confirmatory trials"@en, "early-phase"@en, "early phase"@en, "late-phase"@en, "late phase"@en, "late-stage trial"@en, "late-stage trials"@en ;
  schema:description "The three stages a new drug passes through: phase 1 finds a safe dose in a few dozen patients, phase 2 looks for signs of activity in a hundred or so, and phase 3 compares it with the standard treatment in hundreds or thousands."@en ;
  schema:url <https://onco.cc/terms/trial-phases/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Phases_of_clinical_research> ;
  owl:sameAs <http://www.wikidata.org/entity/Q7180990> ;
  schema:citation <https://en.wikipedia.org/wiki/Phases_of_clinical_research> ;
  onco:related <https://onco.cc/terms/clinical-trial/>, <https://onco.cc/terms/randomised-trial/>, <https://onco.cc/terms/dose/>, <https://onco.cc/terms/endpoint/>, <https://onco.cc/terms/accelerated-approval/>, <https://onco.cc/terms/standard-of-care/>, <https://onco.cc/terms/surrogate-endpoint/>, <https://onco.cc/terms/trial-lifecycle/>, <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/confirmatory-trial/>, <https://onco.cc/terms/first-in-human/>, <https://onco.cc/terms/dose-escalation-design/>, <https://onco.cc/terms/seamless-adaptive/>, <https://onco.cc/terms/single-arm/>, <https://onco.cc/terms/non-inferiority/>, <https://onco.cc/terms/basket-umbrella-platform/>, <https://onco.cc/terms/trial-protocol/>, <https://onco.cc/terms/trial-registration/>, <https://onco.cc/terms/ethics-review/>, <https://onco.cc/terms/informed-consent/>, <https://onco.cc/terms/data-monitoring-committee/>, <https://onco.cc/terms/clinical-equipoise/>, <https://onco.cc/terms/estimand/>, <https://onco.cc/terms/kaplan-meier-curve/>, <https://onco.cc/terms/absolute-benefit/>, <https://onco.cc/terms/surrogate-validation/>, <https://onco.cc/terms/quality-adjusted-survival/>, <https://onco.cc/terms/trial-failure-modes/>, <https://onco.cc/terms/basket-trial/>, <https://onco.cc/terms/umbrella-trial/>, <https://onco.cc/terms/response-adaptive-randomisation/>, <https://onco.cc/terms/bayesian-trial-design/>, <https://onco.cc/terms/sample-size-re-estimation/>, <https://onco.cc/terms/smart-design/>, <https://onco.cc/terms/biomarker-stratified-design/>, <https://onco.cc/terms/pragmatic-trial/>, <https://onco.cc/terms/registry-based-trial/>, <https://onco.cc/terms/decentralised-trial/>, <https://onco.cc/terms/n-of-1-trial/>, <https://onco.cc/terms/cluster-randomised-trial/>, <https://onco.cc/terms/stepped-wedge-design/>, <https://onco.cc/terms/non-inferiority-margin/>, <https://onco.cc/terms/stratified-randomisation/>, <https://onco.cc/terms/group-sequential-design/> ;
  onco:trials <https://onco.cc/trials/navigate/>, <https://onco.cc/trials/rejoice-ovarian01/>, <https://onco.cc/trials/keynote-522/>, <https://onco.cc/trials/adaura/> .